Table 3.

Clinic and pathologic findings in 130 patients with CM, according to CAF-1/p60 expression in radial and vertical growth phase.

CLINICO-PATHOLOGIC FEATURES		CAF-1/P60 radial growth phase							CAF-1/P60 vertical growth phase
	N°	+	%	++	%	+++	%	PVALUE°	+	%	++	%	+++	%	PVALUE°
AGE
≤30	13	9	69,2%	4	30,8%	0	0	NS	3	23,0%	6	46,2%	4	30,8%	NS
>30	117	82	70,0%	35	30%	0	0	NS	44	37,6%	40	34,2%	33	28,2%	NS
STAGING
IA	25	22	88,0%	3	12,0%	0	0	<0,001	19	76,0%	3	12,0%	3	12,0%	<0,001
IB	45	42	93,3%	3	6,7%	0	0	<0,001	19	42,2%	24	53,3%	2	4,5%	<0,001
IIA	28	20	71,4%	8	28,6%	0	0	<0,001	9	32,1%	12	42,8%	7	25,1%	<0,001
IIB	16	3	18,7%	13	81,3%	0	0	<0,001	0	0	3	18,7%	13	81,3%	<0,001
IIC	4	3	75,0%	1	25,0%	0	0	<0,001	0	0	1	25,0%	3	75,0%	<0,001
IIIA	4	1	25,0%	3	75,0%	0	0	<0,001	0	0	1	25,0%	3	75,0%	<0,001
IIIB	7	0	0	7	100%	0	0	<0,001	0	0	0	0	7	100%	<0,001
IV	1	0	0	1	100%	0	0	<0,001	0	0	0	0	1	100%	<0,001
BRESLOW
<1 mm	28	25	89,3%	3	10,7%	0	0	<0,001	19	67,8%	6	21,4%	3	10,8%	<0,001
1.01-2.00 mm	51	41	80,4%	10	19,6%	0	0	<0,001	21	41,2%	22	43,1%	8	15,7%	<0,001
2.01-4.00 mm	41	21	51,2%	20	48,8%	0	0	<0,001	7	17,1%	14	34,1%	20	48,8%	<0,001
>4.00 mm	10	4	40,0%	6	60,0%	0	0	<0,001	0	0	4	40,0%	6	60,0%	<0,001
PROGNOSIS
NO PROGRESSION	95	91	95,8%	4	4,2%	0	0	<0,001	47	49,5%	46	48,4%	2	2,1%	<0,001
S/N/M*	35	0	0	35	100%	0	0	<0,001	0	0	0	0	35	100%	<0,001

*S: skin (dermal/hypodermal) metastasis; N: nodal metastasis; M: distant metastasis; °(P value were calculated by t-test or ANOVA)